检索结果-南通市图书馆

Efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus: a randomized controlled trial

Journal of Traditional Chinese Medicine 2016年第5期36卷 640-648页

作者： Guo Qiang Zhang Hengyao Li Mindian Zhao Ziyi Luo Yunlin Luo Yulei Cao Wenzhai Zhao Huan Zhu Ranran Lei Xingxing Chen Huizhen Gan Huakui zuo zhihuang Chen Qi Shi Cuimei Zhang Xinli Guo Jian Zhong Sen Chen Qiu School of Clinical Medicine Chengdu University of Traditional Chinese Medicine Department of Endocrinology Ningxia Chinese Medicine Research Center Department of Cellular and Molecular Physiology Section of Comparative Medicine and Program in Integrative Cell Signaling and Neurobiology of Metabolism Yale University School of Medicine Department of Central Laboratory Teaching Hospital of Chengdu University of Traditional Chinese Medicine Department of Traditional Chinese Medicine Dujiangyan Traditional Chinese Medicine Hospital Diabetes Center The third Teaching Hospital of Chengdu University of Traditional Chinese Medicine Medical Department of Cardiology Zigong First People's Hospital Medical Department of Neurology Teaching Hospital of Chengdu University of Traditional Chinese Medicine Department of Endocrinology The First People's Hospital of Neijiang Department of Endocrinology The Central Hospital of Guangyuan Department of Endocrinology Zizhong County Hospital of Traditional Chinese Medicine Department of Endocrinology Hospital of traditional Chinese Medicine of Xichang Department of Endocrinology Liangshan Hospital of Integrated Traditional and Western Medicine Department of Endocrinology The Second People's Hospital of Leshan Medical Department of Infections Teaching Hospital of Chengdu University of Traditional Chinese Medicine Medical Department of Endocrinology Teaching Hospital of Chengdu University of Traditional Chinese Medicine

OBJECTIVE: To assess the efficacy and safety of Sancai powder in patients with type 2 diabetes mellitus(T2DM) inadequately controlled with single oral metformin in a randomized controlled trial(RCT).METHODS: A total of 132 patients with T2 DM were enrolled in the study, who only took metformin(500-1000 mg/day) for at least three months and with inadequate glycemic control(7.0% ≤ hemoglobin A1 c ≤ 9.0%) in the past three *** patients stopped taking metformin with lifestyle interventions for three weeks, and 105 patients qualified for the program. They were randomly divided into the Sancai powder group and the metformin group(1500 mg/day). The follow-up period was for 12 weeks. Comparisons of several variables were ***: No significant differences were found between the two groups in hemoglobin A1c(Hb A1c),fasting plasma glucose(FPG) and 2 h post-meal glucose(2h PG), although they had decreased significantly(P < 0.01). Homeostasis model assessment of beta cell function index was significantly improved in Sancai powder group(P < 0.01), and there were significant differences in the changes of homeostasis model assessment of insulin resistance and insulin sensitivity index in the two groups(P < 0.05). Sancai powder significantly reduced triglyceride level(P < 0.05), although there was no significant difference in the body weight and body mass index in the two ***: In this 12-week study, Sancai powder could significantly reduce hemoglobin A1 c,FPG and 2h PG levels, improved beta-cell function and insulin resistance of the T2 DM inadequately controlled with metformin.

关键词： Diabetes Mellitus Type 2 Sancai powder Metformin Treatment outcome Randomized controlled trial

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：